Home/Filings/4/A/0001104659-23-120760
4/A//SEC Filing

Hagopian Henry III 4/A

Accession 0001104659-23-120760

CIK 0001477845other

Filed

Nov 21, 7:00 PM ET

Accepted

Nov 22, 4:21 PM ET

Size

4.9 KB

Accession

0001104659-23-120760

Insider Transaction Report

Form 4/AAmended
Period: 2023-11-20
Hagopian Henry III
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2023-11-20$6.10/sh+820$5,0021,820 total

Issuer

Annovis Bio, Inc.

CIK 0001477845

Entity typeother

Related Parties

1
  • filerCIK 0001821822

Filing Metadata

Form type
4/A
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:21 PM ET
Size
4.9 KB